Categories: News

ProAssurance Corporation Files Supplement to Proxy Statement for Annual Meeting

BIRMINGHAM, Ala.–(BUSINESS WIRE)–ProAssurance Corporation (NYSE:PRA) has filed a supplement with the Securities and Exchange Commission to its previously filed proxy statement for ProAssurance’s annual meeting of shareholders that will be held at 10:00 a.m. ET on May 25, 2021.

The proxy statement supplement informs shareholders of a typographical error related to the disclosure of Kevin M. Shook’s compensation in 2020. The Summary Compensation Table on page 37 of the Proxy Statement erroneously showed that Mr. Shook received $384,562 in 2020 compensation pursuant to the Non-Equity Incentive Plan. The correct number is $348,562. Accordingly, the Summary Compensation Table on page 37 of the Proxy Statement should read that, in 2020, Mr. Shook earned $348,562 in compensation pursuant to the Non-Equity Incentive Plan and $1,216,608 in total compensation.

In addition, the supplement revises the disclosure under the heading “Meetings and Committees of the Board of Directors” on page 14 of the Proxy Statement to report that each of the Company’s incumbent directors attended all of the meetings of the committees of the board on which he or she served during 2020. The Proxy Statement erroneously stated that the Company’s incumbent directors attended at least two thirds of all of the meetings of the committees of the board on which he or she served during 2020.

Except as specifically revised by the information contained herein, the supplement does not modify, amend or otherwise affect any of the other information set forth in the Proxy Statement. The proxy statement supplement may be accessed and copies of the supplement may be obtained without charge in the manner described in ProAssurance’s proxy statement and is also available without charge on the SEC’s website at www.sec.gov. Shareholders may also contact Jeff Lisenby, Executive Vice President and Corporate Secretary of ProAssurance at (800) 282-6242, Ext.362668 for assistance in obtaining the proxy statement and the supplement thereto.

About ProAssurance

ProAssurance Corporation is an industry-leading specialty insurer with extensive expertise in healthcare professional liability, products liability for medical technology and life sciences, legal professional liability, and workers’ compensation insurance. ProAssurance Group is rated “A” (Excellent) by AM Best; ProAssurance and its operating subsidiaries are rated “A-” (Strong) by Fitch Ratings. For the latest on ProAssurance and its industry-leading suite of products and services, cutting-edge risk management and practice enhancement programs, follow @ProAssurance on Twitter or LinkedIn. ProAssurance’s YouTube channel regularly presents thought provoking, insightful videos that communicate effective practice management, patient safety and risk management strategies.

Contacts

Ken McEwen

Manager, Investor Relations

800-282-6242 • 205-439-7903 • KenMcEwen@ProAssurance.com

Staff

Recent Posts

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

3 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

6 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

6 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

6 hours ago